Adcendo ApSCopenhagen-based biotech Adcendo ApS has closed an oversubscribed US$75 million Series C round led by Jeito Capital. The funds will fuel early-phase trials of three ADC candidates for cancers with high unmet need.
Tag Archive for: Jeito Capital
Pic by Immo Wegmann via UnsplashJeito Capital has closed its second dedicated biopharma fund, Jeito II, on a record US$1.2 billion (€1 billion), making it the largest fund ever raised by a fully independent European biopharma-focused private equity firm. The move firmly places Jeito among the leading global backers of clinical stage innovation.
pleiotrope - wikipedia.orgLeuven-based Augustine Therapeutics NV will use the proceeds from a €77.7m in Series A financing led by Novo Holdings and Jeito Capital to advance its preclinical HDAC6 inhibitor AGT-100216 for the treatment of Charcot-Marie-Tooth (CMT) disease to Phase I testing.
Hummingbird BioscienceInvestment company Frazier Life Sciences has launched the virtual ADC company Callio Therapeutics Inc by licencing Hummingbird Bioscience’s TopDDRive dual payload ADC technology and co-leading a US$187m financing round with French Jeito Capital and other investors.